Renin-Angiotensin and Endothelin Systems in Patients Post-Takotsubo Cardiomyopathy.
Hilal KhanAmelia RuddDavid T GambleAlice M MezincescuLesley CheyneGraham W HorganNeeraj DhaunDavid E NewbyDana K DawsonPublished in: Journal of the American Heart Association (2022)
Background We investigate if renin-angiotensin and endothelin-1 response pathways follow the same pattern of recovery as left ventricular ejection fraction in patients with takotsubo cardiomyopathy. Methods and Results Ninety patients with takotsubo cardiomyopathy (n=30 in each of "acute," "convalescent" [3-5 months] and "recovered" [>1 year] groups) who were on minimal or no medication and were free of any significant cardiac/metabolic comorbidities, and 30 controls were studied. Serum concentrations of renin, angiotensin-converting enzyme, angiotensin II, big endothelin-1, endothelin-1 were measured using commercially available ELISA, and B-type natriuretic peptide was measured using an immunoassay. Mean left ventricular ejection fraction was <40% during the acute phase in all groups, but recovered to 63% in convalescent and 64% in the recovered groups, respectively. Serum renin concentrations remain persistently elevated after a episode of takotsubo cardiomyopathy ( P =0.03 versus controls). Angiotensin converting enzyme levels are significantly depressed during the acute phase compared with convalescent ( P =0.004), recovered takotsubo cardiomyopathy ( P =0.02) or controls ( P =0.03). Angiotensin II is increased in patients with takotsubo cardiomyopathy ( P <0.001 versus controls) remaining persistently elevated in the chronically recovered group alone ( P =0.03 versus controls). Big endothelin-1 levels are unchanged, but endothelin-1 is significantly lower after takotsubo cardiomyopathy compared with controls ( P =0.03). Conclusions Despite "normalization" of the left ventricular ejection fraction, there is long-term maladaptive activation of renin-angiotensin system in patients with takotsubo cardiomyopathy. Registration URL: https://www.clinicaltrials.gov; Unique identifiers: NCT02897739, NCT02989454.
Keyphrases
- angiotensin converting enzyme
- ejection fraction
- angiotensin ii
- aortic stenosis
- heart failure
- left ventricular
- vascular smooth muscle cells
- acute myocardial infarction
- cardiac resynchronization therapy
- mitral valve
- transcatheter aortic valve replacement
- chronic kidney disease
- newly diagnosed
- big data
- hypertrophic cardiomyopathy
- end stage renal disease
- intensive care unit
- aortic valve
- hepatitis b virus
- prognostic factors